Medium risk Drugs & MedicationsClass II

Baxter Healthcare Corporation Recall

CARDENE IV (Nicardipine Hydrochloride) in 0.83% Sodium Chloride Injection, 40 mg in 200 mL (0.2 mg/mL) in GALAXY Single-Dose Container, Manu

Updated August 6, 2026

Baxter Healthcare Corporation is recalling CARDENE IV (Nicardipine Hydrochloride) in 0.83% Sodium Chloride Injection, 40 mg in 200 mL (0.2 mg/mL) in GALAXY Single-Dose Container, Manu. Hazard: CGMP Deviations

Is the Baxter Healthcare Corporation recalled? Yes. This product was recalled by FDA on August 6, 2026. Details below.

What is recalled

CARDENE IV (Nicardipine Hydrochloride) in 0.83% Sodium Chloride Injection, 40 mg in 200 mL (0.2 mg/mL) in GALAXY Single-Dose Container, Manufactured and Marketed by: Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 43066-016-10.

Am I affected

You may be affected if you own this product. Check the brand, model, and lot/date codes listed in the recall against your item.

What to do right now

Voluntary: Firm initiated

The hazard

CGMP Deviations

Brands affected

Source
FDA
Category
Drugs & Medications
Recall ID
fda-D-0813-2026
Classification
Class II
Recalled
August 6, 2026
Read the official notice

Get free recall alerts

New Drugs & Medications recalls, the moment they post.

Free forever. Unsubscribe anytime. We never sell your data.

More Drugs & Medications recalls